CASE CONTROL STUDY OF LEVETIRACETAM VS. FOSPHENYTOIN FOR SEIZURE PROPHYLAXIS IN CHILDREN RECEIVING BUSULFAN (BU) FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

被引：0
|
作者：
Skeens, M. A.
Soni, S.
Pai, V
Bajwa, R.
Pietryga, D.
Gross, T.
Termuhlen, A.
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [31] Secondary antifungal prophylaxis with liposomal amphotericin B (AmB-L) in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT)
    Busca, Alessandro
    D'Ardia, Stefano
    Terruzzi, Elisabetta
    Pogliani, Enrico
    Alessandrino, Emilio Paolo
    Griva, Vassiliki
    Deliliers, Giorio Lambertenghi
    BLOOD, 2007, 110 (11) : 320B - 320B
  • [32] Phase II study of targeted busulfan(BU) and cyclophosphamide(CY) as conditioning for allogeneic hemopoietic stem cell transplantation (HSCT) in patients with myelodysplasia (MDS).
    Getzendaner, L
    Storer, B
    Anasetti, C
    Slattery, J
    Chauncey, T
    Storb, R
    Hansen, J
    Sanders, J
    Appelbaum, F
    Deeg, J
    BLOOD, 2000, 96 (11) : 584A - +
  • [33] Bacteremia during Neutropenic Episodes in Children Underwent Hematopoietic Stem Cell Transplantation Receiving Ciprofloxacin and Penicillin Prophylaxis
    Choeyprasert, Worawut
    Pakakasama, Samart
    Hongeng, Suradej
    Anurathapan, Usanarat
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S246 - S247
  • [34] CHILDREN'S COPING WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): RESULTS FROM THE JOURNEYS TO RECOVERY STUDY
    Kent, Michael W.
    Ratichek, Sara J.
    Kupst, Mary Jo
    Bingen, Kristin
    Recklitis, Christopher
    Chang, Grace
    Tighiouart, Hocine
    Terrin, Norma
    Parsons, Susan K.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 702 - 702
  • [35] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    Curtis, P. Huezo-Diaz
    Uppugunduri, C. R. S.
    Muthukumaran, J.
    Rezgui, M. A.
    Peters, C.
    Bader, P.
    Duval, M.
    Bittencourt, H.
    Krajinovic, Maja
    Ansari, Marc
    PHARMACOGENOMICS JOURNAL, 2018, 18 (01): : 64 - 69
  • [36] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    P Huezo-Diaz Curtis
    C R S Uppugunduri
    J Muthukumaran
    M A Rezgui
    C Peters
    P Bader
    M Duval
    H Bittencourt
    Maja Krajinovic
    Marc Ansari
    The Pharmacogenomics Journal, 2018, 18 : 64 - 69
  • [37] Clinical Comparison of Weight and Age Based Strategy of Dose Administration in Children Receiving Intravenous Busulfan for Hematopoietic Stem Cell Transplantation
    Gokcebay, D. Gurlek
    Azik, F.
    Ozbek, N.
    Isik, P.
    Avci, Z.
    Tavil, B.
    Tunc, B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S225 - S226
  • [38] REITERATED THERAPEUTIC DRUG MONITORING (TDM) TO BETTER CONTROL TARGETED EXPOSURE TO IV BUSULFAN IN INFANTS AND OLDER CHILDREN UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT)
    Bourget, P.
    Neven, B.
    Amin, A.
    Chomton, M.
    Cros, G.
    Elkaim, E.
    Fremond, M. -L.
    Moshous, D.
    Touzot, F.
    Ader, F.
    Lalli, A.
    Petain, A.
    Nguyen, L.
    Blanche, S.
    HAEMATOLOGICA, 2015, 100 : 281 - 281
  • [39] Comparison of the outcomes following conventional hematopoietic stem cell transplantation (HSCT) vs. reduced-intensity stem cell transplantation (RIST) in older patients with hematologic malignancies.
    Kojima, R
    Kami, M
    Tanaka, Y
    Kusumi, E
    Kanda, Y
    Mori, S
    Yoshioka, S
    Tajima, K
    Fujisawa, S
    Kariamori, H
    Morishima, S
    Sao, H
    Kasai, M
    Kasai, M
    Taniguchi, S
    Sakamaki, H
    Hirai, H
    Harada, M
    Takaue, Y
    BLOOD, 2003, 102 (11) : 732A - 732A
  • [40] Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study
    Jansing, Thaksin
    Sanpakit, Kleebsabai
    Tharnpanich, Trai
    Jiranantakan, Thanjira
    Niphandwongkorn, Vachira
    Chindavijak, Busba
    Suansanae, Thanarat
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (04) : 346 - 357
12345